Published in J Gen Intern Med on October 23, 2007
Underweight body mass index is a risk factor of mortality in outpatients with nocturia in Japan. BMC Res Notes (2015) 1.39
Body mass index and all-cause mortality in a large Chinese cohort. CMAJ (2011) 1.15
Association between sleep duration and mortality is mediated by markers of inflammation and health in older adults: the Health, Aging and Body Composition Study. Sleep (2015) 0.94
Is there a reversal in the effect of obesity on mortality in old age? J Aging Res (2011) 0.87
Implant-supported mandibular overdentures in very old adults: a randomized controlled trial. J Dent Res (2013) 0.86
Impact of body mass index on risk of acute kidney injury and mortality in elderly patients undergoing hip fracture surgery. Osteoporos Int (2016) 0.81
Larger body mass index and waist circumference are associated with lower mortality in Chinese long-term care facility residents. J Am Geriatr Soc (2010) 0.80
The effect of obesity on incidence of disability and mortality in Mexicans aged 50 years and older. Salud Publica Mex (2015) 0.78
The dynamic association of body mass index and all-cause mortality in multiple cohorts and its impacts. Emerg Themes Epidemiol (2014) 0.77
Increased 1-year survival and discharge to independent living in overweight hip fracture patients. Acta Orthop (2016) 0.75
Analysis of the Prevalence and Factors Associated with Nocturia in Adult Korean Men. Sci Rep (2017) 0.75
Body mass index, risk of allogeneic red blood cell transfusion, and mortality in elderly patients undergoing hip fracture surgery. Osteoporos Int (2016) 0.75
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med (2003) 35.39
Excess deaths associated with underweight, overweight, and obesity. JAMA (2005) 22.17
The disease burden associated with overweight and obesity. JAMA (1999) 19.39
Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med (1999) 16.57
Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med (2006) 16.17
Obesity as a medical problem. Nature (2000) 15.12
The effect of age on the association between body-mass index and mortality. N Engl J Med (1998) 13.94
Body weight and mortality among women. N Engl J Med (1995) 11.04
Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med (2004) 8.63
Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet (2006) 8.61
Body-mass index and mortality in Korean men and women. N Engl J Med (2006) 7.50
Guidelines for healthy weight. N Engl J Med (1999) 7.03
Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med (2002) 6.92
The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med (2005) 5.86
Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int (2003) 5.37
Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. JAMA (1995) 4.78
An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J (2007) 3.62
Health consequences of obesity in the elderly: a review of four unresolved questions. Int J Obes (Lond) (2005) 3.41
Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol (2004) 3.08
An evidence-based assessment of federal guidelines for overweight and obesity as they apply to elderly persons. Arch Intern Med (2001) 2.46
Body mass index and mortality among hospitalized patients. Arch Intern Med (2000) 2.29
Weight, shape, and mortality risk in older persons: elevated waist-hip ratio, not high body mass index, is associated with a greater risk of death. Am J Clin Nutr (2006) 2.19
Body mass index is inversely related to mortality in older people after adjustment for waist circumference. J Am Geriatr Soc (2005) 2.15
The effects of physical activity and body mass index on cardiovascular, cancer and all-cause mortality among 47 212 middle-aged Finnish men and women. Int J Obes (Lond) (2005) 2.05
Effect of obesity and being overweight on long-term mortality in congestive heart failure: influence of left ventricular systolic function. Eur Heart J (2004) 2.04
Orthostatic hypotension in acute geriatric ward: is it a consistent finding? Arch Intern Med (2002) 1.81
Mortality associated with body fat, fat-free mass and body mass index among 60-year-old swedish men-a 22-year follow-up. The study of men born in 1913. Int J Obes Relat Metab Disord (2000) 1.78
Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med (2005) 1.77
Obesity, physical activity, and mortality in a prospective chinese elderly cohort. Arch Intern Med (2006) 1.57
The body mass index-mortality relationship in white and African American women. Obes Res (1998) 1.38
Differential associations of body mass index and adiposity with all-cause mortality among men in the first and second National Health and Nutrition Examination Surveys (NHANES I and NHANES II) follow-up studies. Int J Obes Relat Metab Disord (2002) 1.37
The influence of nutritional status on complications after operations for lung cancer. Ann Thorac Surg (2001) 1.21
Comparison of ideal body weight equations and published height-weight tables with body mass index tables for healthy adults in the United States. Nutr Clin Pract (2006) 1.07
Lifestyle determinants and mortality in German vegetarians and health-conscious persons: results of a 21-year follow-up. Cancer Epidemiol Biomarkers Prev (2005) 0.90
Impact of body mass index on short-term outcome after acute myocardial infarction: does excess body weight have a paradoxical protective role? Int J Cardiol (2006) 0.86
Body mass index and mortality in a middle-aged Japanese cohort. J Epidemiol (2005) 0.85
The impact of obesity on survival in patients with heart failure. Heart Fail Monit (2002) 0.82
Body mass and 26 y risk of mortality among men who never smoked: a re-analysis among men from the Adventist Mortality Study. Int J Obes Relat Metab Disord (1998) 0.80
Fatal infectious disease surveillance in a medical examiner database. Emerg Infect Dis (2004) 0.79
Body mass index as a predictor of mortality in community-dwelling seniors. Aging Clin Exp Res (2006) 0.78
Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med (2008) 5.86
Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry. Circulation (2012) 3.30
A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus. Am J Cardiol (2007) 3.07
Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. Lancet (2009) 2.82
Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials. Lancet Oncol (2010) 2.77
A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease. J Am Coll Cardiol (2005) 2.56
Remifentanil: a novel systemic analgesic for labor pain. Anesth Analg (2005) 2.23
Pre-hypertension is a common phenomenon: national database study. Isr Med Assoc J (2007) 2.05
Inter-arm blood pressure differences in young, healthy patients. J Clin Hypertens (Greenwich) (2013) 2.04
Incretin, insulinotropic and glucose-lowering effects of whey protein pre-load in type 2 diabetes: a randomised clinical trial. Diabetologia (2014) 2.02
Stem cell therapy in perspective. Circulation (2003) 1.88
Progression of normotensive adolescents to hypertensive adults: a study of 26,980 teenagers. Hypertension (2010) 1.87
Orthostatic hypotension in acute geriatric ward: is it a consistent finding? Arch Intern Med (2002) 1.81
Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol (2011) 1.72
Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. N Engl J Med (2010) 1.70
Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol (2008) 1.67
The effect of cardiac angiography timing, contrast media dose, and preoperative renal function on acute renal failure after coronary artery bypass grafting. J Thorac Cardiovasc Surg (2009) 1.62
Stroke complicating percutaneous coronary interventions: incidence, predictors, and prognostic implications. Circulation (2002) 1.61
Identification of the epidural space: loss of resistance with air, lidocaine, or the combination of air and lidocaine. Anesth Analg (2004) 1.59
Coronary calcium by spiral computed tomography predicts cardiovascular events in high-risk hypertensive patients. J Hypertens (2004) 1.57
Circulating endothelial progenitor cell levels and function in patients who experienced late coronary stent thrombosis. Eur Heart J (2010) 1.56
Treatment with insulin sensitizer metformin improves arterial properties, metabolic parameters, and liver function in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial. Metabolism (2011) 1.54
The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction. Catheter Cardiovasc Interv (2010) 1.53
Increased epicardial adipose tissue thickness as a predictor for hypertension: a cross-sectional observational study. J Clin Hypertens (Greenwich) (2013) 1.53
[Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation]. G Ital Cardiol (Rome) (2009) 1.52
Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. J Am Coll Cardiol (2003) 1.51
Predistention of the epidural space before catheter insertion reduces the incidence of intravascular epidural catheter insertion. Anesth Analg (2007) 1.50
Percutaneous coronary intervention for chronic total occlusion: novel 3-dimensional imaging and quantitative analysis. Catheter Cardiovasc Interv (2008) 1.50
Prevalence of myocardial bridging detected with 64-slice multidetector coronary computed tomography angiography in asymptomatic adults. J Cardiovasc Comput Tomogr (2007) 1.50
Does a colonoscopy after acute diverticulitis affect its management?: a single center experience. J Clin Gastroenterol (2012) 1.50
Diagnosing brain death using the transcranial Doppler with a transorbital approach. Arch Neurol (2002) 1.46
Impact of bivalirudin therapy in high-risk patients with acute myocardial infarction: 1-year results from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trial. JACC Cardiovasc Interv (2010) 1.46
Endothelial progenitor cell function inversely correlates with long-term glucose control in diabetic patients: association with the attenuation of the heme oxygenase-adiponectin axis. Can J Cardiol (2012) 1.46
Predictors and course of high-degree atrioventricular block after transcatheter aortic valve implantation using the CoreValve Revalving System. Am J Cardiol (2011) 1.45
Antihypertensive therapy and new onset diabetes. J Hypertens (2004) 1.45
Transcatheter closure of large congenital coronary-cameral fistulae with Amplatzer devices. Catheter Cardiovasc Interv (2010) 1.44
Assessment of target organ damage in the evaluation and follow-up of hypertensive patients: where do we stand? J Clin Hypertens (Greenwich) (2013) 1.44
Three-year outcomes of percutaneous coronary intervention with next-generation zotarolimus-eluting stents for de novo coronary bifurcation lesions. J Invasive Cardiol (2014) 1.43
Exaggerated blood pressure response to exercise is not associated with masked hypertension in patients with high normal blood pressure levels. J Clin Hypertens (Greenwich) (2014) 1.43
Impact of female sex on long-term acute coronary syndrome outcomes. Coron Artery Dis (2015) 1.42
The impact of renal insufficiency on patients' outcomes in emergent angioplasty for acute myocardial infarction. Catheter Cardiovasc Interv (2007) 1.42
A comparative analysis of major clinical outcomes using drug-eluting stents versus bare-metal stents in a large consecutive patient cohort. Catheter Cardiovasc Interv (2010) 1.41
The effect of intermittent versus continuous bladder catheterization on labor duration and postpartum urinary retention and infection: a randomized trial. J Clin Anesth (2008) 1.41
A comparative analysis of major clinical outcomes using drug-eluting stents versus bare metal stents in diabetic versus nondiabetic patients. Catheter Cardiovasc Interv (2011) 1.41
Predictors of failed colonoscopy in nonagenarians: a single-center experience. J Clin Gastroenterol (2007) 1.41
Long-term outcomes after percutaneous coronary interventions in cancer survivors. Coron Artery Dis (2017) 1.40
Femoral vascular closure device use, bivalirudin anticoagulation, and bleeding after primary angioplasty for STEMI: results from the HORIZONS-AMI trial. Catheter Cardiovasc Interv (2014) 1.40
Long-term outcomes of patients with complex coronary artery disease according to agreement between the SYNTAX score and revascularization procedure in contemporary practice. Coron Artery Dis (2014) 1.40
The risk of cardiac complications following noncardiac surgery in patients with drug eluting stents implanted at least six months before surgery. Catheter Cardiovasc Interv (2009) 1.40
Predictors of high-risk angiographic findings in patients with non-ST-segment elevation acute coronary syndrome. Catheter Cardiovasc Interv (2013) 1.39
Diagnostic clues for identification of nonorganic vs organic causes of food refusal and poor feeding. J Pediatr Gastroenterol Nutr (2009) 1.39
Percutaneous implantation of the self-expandable CoreValve for high risk patients with severe aortic valve stenosis: early Israeli experience. Isr Med Assoc J (2010) 1.39
Prognostic value of left ventricular dyssynchrony by myocardial perfusion-gated SPECT in patients with normal and abnormal left ventricular functions. J Nucl Cardiol (2014) 1.39
Efficacy and Safety of Novel NovaCross Microcatheter for Chronic Total Occlusions: First-in-Human Study. J Invasive Cardiol (2016) 1.39
Acute and intermediate-term results of percutaneus left main coronary artery interventions. Isr Med Assoc J (2004) 1.39
Drug eluting stenting in bifurcation coronary lesions long-term results applying a systematic treatment strategy. Catheter Cardiovasc Interv (2011) 1.39
Retroperitoneal bleeding after cardiac catheterization: a 7-year descriptive single-center experience. Cardiology (2013) 1.39
Efficacy and Safety of Transcatheter Aortic Valve Implantation in Aortic Stenosis Patients With Extreme Age. J Invasive Cardiol (2015) 1.39
Initial experience with the Amplatzer membranous septal occluder in adults. Acute Card Care (2007) 1.38
Differential role and tissue specificity of interleukin-1alpha gene expression in atherogenesis and lipid metabolism. Atherosclerosis (2006) 1.34
Determination of arterial compliance using blood pressure waveform analysis with the CR-2000 system: Reliability, repeatability, and establishment of normal values for healthy European population--the seven European sites study (SESS). Am J Hypertens (2005) 1.33
Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention. Am J Cardiol (2007) 1.32
Comparison of clinical characteristics of patients with gastroesophageal reflux disease who failed proton pump inhibitor therapy versus those who fully responded. J Neurogastroenterol Motil (2011) 1.32
Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum (2010) 1.31
Application of Maastricht 2-2000 guidelines for the management of Helicobacter pylori among specialists and primary care physicians in israel: are we missing the malignant potential of Helicobacter pylori? J Clin Gastroenterol (2004) 1.27
Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality. Am J Cardiol (2006) 1.26
Prolactin and autoimmunity. Autoimmun Rev (2011) 1.24
A prospective national survey of management and clinical outcome of acute myocardial infarction in Israel, 2000. Isr Med Assoc J (2003) 1.24
Prevalence of prehypertension and associated cardiovascular risk profiles among young Israeli adults. Hypertension (2006) 1.23
Peripartum hypertension from pheochromocytoma: a rare and challenging entity. Am J Hypertens (2005) 1.23
Severe hypophosphatemia in sepsis as a mortality predictor. Ann Clin Lab Sci (2006) 1.23
Efficacy of ozone-oxygen therapy for the treatment of diabetic foot ulcers. Diabetes Technol Ther (2011) 1.16
Treatment of aspirin-resistant patients with omega-3 fatty acids versus aspirin dose escalation. J Am Coll Cardiol (2010) 1.15
Results of percutaneous coronary interventions in patients > or =90 years of age. Catheter Cardiovasc Interv (2007) 1.14
Does dietary recall adequately assess sodium, potassium, and calcium intake in hypertensive patients? Nutrition (2005) 1.14
Prompt correction of endotracheal tube positioning after intubation prevents further inappropriate positions. J Clin Anesth (2011) 1.13
Percutaneous closure of perivalvular leaks with Amplatzer occluders: feasibility, safety, and shortterm results. J Heart Valve Dis (2007) 1.13
Continuity and adherence to long-term drug treatment by geriatric patients after hospital discharge: a prospective cohort study. Drugs Aging (2008) 1.12
Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. J Am Coll Cardiol (2009) 1.12
Coronary angioplasty after self-expandable transcatheter aortic valve implantation. J Invasive Cardiol (2013) 1.12
Paclitaxel-eluting stents compared with bare metal stents in diabetic patients with acute myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial. Circ Cardiovasc Interv (2011) 1.11
The impact of circadian variation on outcomes in emergency acute anterior myocardial infarction percutaneous coronary intervention. Catheter Cardiovasc Interv (2006) 1.11
Prospective, Randomized, Multicenter Evaluation of a Polyethylene Terephthalate Micronet Mesh-Covered Stent (MGuard) in ST-Segment Elevation Myocardial Infarction: The MASTER Trial. J Am Coll Cardiol (2012) 1.09
Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. JACC Cardiovasc Interv (2011) 1.08
Effect of PPAR-gamma agonist on adiponectin levels in the metabolic syndrome: lessons from the high fructose fed rat model. Am J Hypertens (2007) 1.07
Preliminary experience using the transcatheter mitral valve leaflet repair procedure. Isr Med Assoc J (2013) 1.07
Extrapancreatic autoimmune manifestations in type 1 diabetes patients and their first-degree relatives: a multicenter study. Diabetes Care (2003) 1.06
Olive leaf extract as a hypoglycemic agent in both human diabetic subjects and in rats. J Med Food (2012) 1.06
Nocardiosis: a 15-year experience in a tertiary medical center in Israel. Eur J Intern Med (2013) 1.05
Pediatric Crohn's disease and growth retardation: the role of genotype, phenotype, and disease severity. Pediatrics (2004) 1.05
Epicardial adipose tissue as a predictor of coronary artery disease in asymptomatic subjects. Am J Cardiol (2012) 1.05
Relationship of in-hospital medication modifications of elderly patients to postdischarge medications, adherence, and mortality. Ann Pharmacother (2008) 1.04
Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease. Am J Cardiol (2006) 1.03
Impaired nocturnal melatonin secretion in non-dipper hypertensive patients. Blood Press (2003) 1.02
Metabolic syndrome: comparison of the two commonly used animal models. Am J Hypertens (2008) 1.01